Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2021 Publisher: Teva UK Limited, Brampton Road, Hampden Park, Eastbourne, East Sussex, BN22 9AG, United Kingdom
COLOMYCIN 1 million International Units (IU).
Powder for solution for injection, infusion or inhalation.
| Pharmaceutical Form |
|---|
|
Powder for solution for injection, infusion or inhalation. Sterile white powder in a 10ml colourless glass vial with a red ‘flip-off’ cap. |
Each vial contains 1 million IU colistimethate sodium.
| Active Ingredient | Description | |
|---|---|---|
| Colistimethate |
Colistimethate is a cyclic polypeptide antibacterial active substance that is derived from Bacillus polymyxa var colistinus and belongs to the polymyxin group. Polymyxins work by damaging the cell membrane and the resulting physiological effects are lethal to the bacterium. Polymyxins are selective for Gram-negative bacteria that have a hydrophobic outer membrane. |
| List of Excipients |
|---|
|
None. |
Type I, 10 ml nominal capacity glass vial with red ‘flip-off’ cap supplied in cartons of 10, 56 or 60 vials.
Not all pack sizes may be marketed.
Teva UK Limited, Brampton Road, Hampden Park, Eastbourne, East Sussex, BN22 9AG, United Kingdom
PL 00289/2255
Date of first authorisation: 04 June 1986
Date of latest renewal: 07 November 2006
| Drug | Countries | |
|---|---|---|
| COLOMYCIN | Estonia, Hong Kong, Ireland, Lithuania, United Kingdom |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
